Cas:203-85-0 1,3-Dihydro-2-thiaphenalene manufacturer & supplier

We serve Chemical Name:1,3-Dihydro-2-thiaphenalene CAS:203-85-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1,3-Dihydro-2-thiaphenalene

Chemical Name:1,3-Dihydro-2-thiaphenalene
CAS.NO:203-85-0
Synonyms:1H.3H-Naphtho<1.8>thiopyran;2H,6H-naphtho<1,8-cd>thiin;1.3-Dihydro-2-thiophenalen;1H,3H-Naphtho(1,8-cd)thiopyran;1H.3H-Naphtho<1.8>thiapyran;1H,8-cd]thiopyran
Molecular Formula:C12H10S
Molecular Weight:186.27300
HS Code:2930909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:372.4ºC at 760mmHg
Density:1.224g/cm3
Index of Refraction:1.715
PSA:25.30000
Exact Mass:186.05000
LogP:3.58660

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1H.3H-Naphtho&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H,8-cd]thiopyran physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H,3H-Naphtho(1,8-cd)thiopyran Use and application,1H,8-cd]thiopyran technical grade,usp/ep/jp grade.


Related News: “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. 6,10-Dioxaspiro[4.5]dec-2-ene, 2,3-difluoro-8,8-dimethyl- manufacturers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. (2’R,5’R,2’R,5’R,1”R,5”S)-1-[5′-(5′-(1”,5”-Di(tert-butyldimethylsilyloxy)undecan-1”-yl)tetrahydrofuran-2′-yl)tetrahydrofuran-2′-yl]-13-(2”,3”,4”,5”-tetramethoxy-6”-methylphenyl)tridecan-1-one suppliers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, 2,2,4,4,6,6-hexahydroxy-24,44,64-heptaoxidane vendor & factory.